Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious Covid-19 infection.

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults with certain health conditions that puts them at risk will be approved for the shot.

A widely available drug for urinary tract infections has never been formally approved by the US government. It’s not the only one.

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift

A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children

The FDA announced it will be taking action to remove prescription drug products with ingestible fluoride for children from the market.

The voluntary recall was prompted after routine testing. It is the second such recall recently of baby food over possible lead contamination.

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy